These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 34804067)
1. The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis. Fuentelsaz-Romero S; Barrio-Alonso C; García Campos R; Torres Torresano M; Muller IB; Triguero-Martínez A; Nuño L; Villalba A; García-Vicuña R; Jansen G; Miranda-Carús ME; González-Álvaro I; Puig-Kröger A Front Immunol; 2021; 12():776879. PubMed ID: 34804067 [TBL] [Abstract][Full Text] [Related]
2. Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism. Municio C; Dominguez-Soto Á; Fuentelsaz-Romero S; Lamana A; Montes N; Cuevas VD; Campos RG; Pablos JL; González-Álvaro I; Puig-Kröger A Ann Rheum Dis; 2018 May; 77(5):752-759. PubMed ID: 29431121 [TBL] [Abstract][Full Text] [Related]
3. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets. Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y Front Immunol; 2018; 9():2228. PubMed ID: 30319663 [TBL] [Abstract][Full Text] [Related]
4. Methotrexate selectively targets human proinflammatory macrophages through a thymidylate synthase/p53 axis. Municio C; Soler Palacios B; Estrada-Capetillo L; Benguria A; Dopazo A; García-Lorenzo E; Fernández-Arroyo S; Joven J; Miranda-Carús ME; González-Álvaro I; Puig-Kröger A Ann Rheum Dis; 2016 Dec; 75(12):2157-2165. PubMed ID: 26920997 [TBL] [Abstract][Full Text] [Related]
5. FcγRIIIa expression on monocytes in rheumatoid arthritis: role in immune-complex stimulated TNF production and non-response to methotrexate therapy. Cooper DL; Martin SG; Robinson JI; Mackie SL; Charles CJ; Nam J; ; Isaacs JD; Emery P; Morgan AW PLoS One; 2012; 7(1):e28918. PubMed ID: 22235253 [TBL] [Abstract][Full Text] [Related]
6. Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients. van der Heijden JW; Assaraf YG; Gerards AH; Oerlemans R; Lems WF; Scheper RJ; Dijkmans BA; Jansen G Scand J Rheumatol; 2014; 43(1):9-16. PubMed ID: 23987246 [TBL] [Abstract][Full Text] [Related]
7. The number of circulating monocytes as biomarkers of the clinical response to methotrexate in untreated patients with rheumatoid arthritis. Chara L; Sánchez-Atrio A; Pérez A; Cuende E; Albarrán F; Turrión A; Chevarria J; del Barco AA; Sánchez MA; Monserrat J; Prieto A; de la Hera A; Sanz I; Diaz D; Alvarez-Mon M J Transl Med; 2015 Jan; 13():2. PubMed ID: 25592233 [TBL] [Abstract][Full Text] [Related]
8. MYD88, IRAK3 and Rheumatoid Arthritis pathogenesis: Analysis of differential gene expression in CD14 + monocytes and the inflammatory cytokine levels. Gomes da Silva IIF; Barbosa AD; Souto FO; Maia MMD; Crovella S; Souza PRE; Sandrin-Garcia P Immunobiology; 2021 Nov; 226(6):152152. PubMed ID: 34735922 [TBL] [Abstract][Full Text] [Related]
9. Pathological significance of elevated soluble CD14 production in rheumatoid arthritis: in the presence of soluble CD14, lipopolysaccharides at low concentrations activate RA synovial fibroblasts. Yu S; Nakashima N; Xu BH; Matsuda T; Izumihara A; Sunahara N; Nakamura T; Tsukano M; Matsuyama T Rheumatol Int; 1998; 17(6):237-43. PubMed ID: 9592864 [TBL] [Abstract][Full Text] [Related]
10. Baseline adenosine receptor mRNA expression in blood as predictor of response to methotrexate therapy in patients with rheumatoid arthritis. Singh A; Misra R; Aggarwal A Rheumatol Int; 2019 Aug; 39(8):1431-1438. PubMed ID: 31203399 [TBL] [Abstract][Full Text] [Related]
11. Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy. Sakamoto N; Hara S; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kakugawa T; Yamaguchi H; Obase Y; Kushima H; Ishii H; Noguchi S; Kido T; Kobayashi T; Soejima Y; Yoshioka S; Ishimatsu Y; Yatera K; Kadota JI; Mukae H Tohoku J Exp Med; 2019 Jul; 248(3):209-216. PubMed ID: 31366819 [TBL] [Abstract][Full Text] [Related]
12. The importance of inhibition of a catabolic pathway of methotrexate metabolism in its efficacy for rheumatoid arthritis. Morgan SL; Baggott JE Med Hypotheses; 2019 Jan; 122():10-15. PubMed ID: 30593388 [TBL] [Abstract][Full Text] [Related]
13. Inflammation specific environment activated methotrexate-loaded nanomedicine to treat rheumatoid arthritis by immune environment reconstruction. Tian J; Chen T; Huang B; Liu Y; Wang C; Cui Z; Xu H; Li Q; Zhang W; Liang Q Acta Biomater; 2023 Feb; 157():367-380. PubMed ID: 36513249 [TBL] [Abstract][Full Text] [Related]
14. Role of SLC7A5 in Metabolic Reprogramming of Human Monocyte/Macrophage Immune Responses. Yoon BR; Oh YJ; Kang SW; Lee EB; Lee WW Front Immunol; 2018; 9():53. PubMed ID: 29422900 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA Expression Differences in Blood-Derived CD19+ B Cells of Methotrexate Treated Rheumatoid Arthritis Patients. Heinicke F; Zhong X; Flåm ST; Breidenbach J; Leithaug M; Mæhlen MT; Lillegraven S; Aga AB; Norli ES; Mjaavatten MD; Haavardsholm EA; Zucknick M; Rayner S; Lie BA Front Immunol; 2021; 12():663736. PubMed ID: 33897713 [TBL] [Abstract][Full Text] [Related]
16. IgG Fc galactosylation predicts response to methotrexate in early rheumatoid arthritis. Lundström SL; Hensvold AH; Rutishauser D; Klareskog L; Ytterberg AJ; Zubarev RA; Catrina AI Arthritis Res Ther; 2017 Aug; 19(1):182. PubMed ID: 28793911 [TBL] [Abstract][Full Text] [Related]
17. Increased circulating CD14brightCD16+ intermediate monocytes are regulated by TNF-α and IL-6 axis in accordance with disease activity in patients with rheumatoid arthritis. Tsukamoto M; Suzuki K; Seta N; Takeuchi T Clin Exp Rheumatol; 2018; 36(4):540-544. PubMed ID: 29465348 [TBL] [Abstract][Full Text] [Related]